Author:
Cleary James M.,Rosen Lee S.,Yoshida Kenichiro,Rasco Drew,Shapiro Geoffrey I.,Sun Weijing
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference12 articles.
1. Wilson PM, Danenberg PV, Johnston PG, Lenz HJ, Ladner RD (2014) Standing the test of time: targeting thymidylate biosynthesis in cancer therapy. Nat Rev Clin Oncol 11:282–298. doi: 10.1038/nrclinonc.2014.51
2. Heidelberger C, Anderson SW (1964) Fluorinated pyrimidines. XXI. The tumor-inhibitory activity of 5-trifluoromethyl-2-deoxyuridine. Cancer Res 24:1979–1985
3. Fukushima M, Suzuki N, Emura T, Yano S, Kazuno H, Tada Y, Yamada Y, Asao T (2000) Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides. Biochem Pharmacol 59:1227–1236
4. Lenz H-J, Stintzing S, Loupakis F (2015) TAS-102, a novel antitumor agent: a review of the mechanism of action. Cancer Treat Rev 41:777–783. doi: 10.1016/j.ctrv.2015.06.001
5. Dexter DL, Wolberg WH, Ansfield FJ, Helson L, Heidelberger C (1972) The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine. Cancer Res 32:247–253
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献